CVS Health (CVS) earnings Q3 2025
Signage for a CVS pharmacy in Takoma Park, Maryland, US, on Wednesday, July 9, 2025. Al Drago |…
Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery
Eli Lilly and Nvidia are partnering to build what they call the pharmaceutical industry’s “most powerful” supercomputer and…
JMIR Article Argues Misapplied Pharmaceutical Model Prevents Scaling of Effective Interventions
Newswise — (Toronto, October 28, 2025) JMIR Publications today released a new article in its growing “News &…
Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell You
ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like…
I’m stuck in the gray market for GLP-1s
On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
Novo Nordisk chair and directors quit after boardroom rift
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
‘Girl, Take Your Crazy Pills!’ Antidepressants Recast as a Hot Lifestyle Accessory
Corinne Byerley, a stay-at-home mom, recalled days when she felt lonely, overwhelmed and, at times, paralyzed with anxiety…
Largest study of African American brain tissue reveals key Alzheimer gene activity
The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry…
What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…
Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
Big Pharma’s retreat: Is NHS pricing behind investor pullbacks?
ADVERTISEMENT Relations between Big Pharma and the UK government are under growing strain. Just last week, Eli Lilly…